A detailed history of Bank & Trust CO transactions in Moderna, Inc. stock. As of the latest transaction made, Bank & Trust CO holds 306 shares of MRNA stock, worth $15,853. This represents 0.02% of its overall portfolio holdings.

Number of Shares
306
Previous 306 -0.0%
Holding current value
$15,853
Previous $36.3 Million 43.72%
% of portfolio
0.02%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$101.21 - $166.61 $30,970 - $50,982
306 New
306 $36.3 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank & Trust CO Portfolio

Follow Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank & Trust CO with notifications on news.